project id: TCGA-ESCA; case submitter id: TCGA-R6-A6XG; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.41; rna integrity number: 8.0; age at index: 64; days to birth: -23484; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 23484; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1168.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Yes; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 728; days to sample procurement: 0; initial weight: 5.0; sample id: 733f1fef-c0c6-48ee-9624-1fcdc682d79e; sample submitter id: TCGA-R6-A6XG-01B; portion id: c2327a19-bc8f-4015-a29e-07cf5ec899fd; portion submitter id: TCGA-R6-A6XG-01B-11; slide id: 88bc85d3-7ef7-4d0a-88dc-1a837084d715; slide submitter id: TCGA-R6-A6XG-01Z-00-DX1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;